Clinical Trial

The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

Study acronym: AFR Registry
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to monitor the safety and efficacy of Occlutech AFR device in patients with Heart Failure.
Protocol Amendment History 1 change
minor Completion pushed: 2027-10 -> 2031-06 2026-05-30
Trial Details
NCT Number NCT04405583
Lead Sponsor Occlutech International AB
Conditions Heart Failure
Enrollment 150 participants
Start Date 2020-10-28
Primary Completion 2027-06-30 (estimated)
Study Completion 2031-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-08